iBio (IBIO) Projected to Post Quarterly Earnings on Friday

iBio (NYSEAMERICAN:IBIO) is expected to announce its earnings results before the market opens on Friday, February 14th. Analysts expect the company to announce earnings of ($0.45) per share for the quarter.

iBio Price Performance

IBIO opened at $3.59 on Friday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.04. iBio has a 1-year low of $1.05 and a 1-year high of $4.98.

About iBio

iBio, Inc, a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases. The company’s technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein.